Interferon Gamma Mediates Hematopoietic Stem Cell Activation and Niche Relocalization through BST2. 2020

Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
Medical Scientist Training Program and Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

During chronic infection, the inflammatory cytokine interferon gamma (IFNγ) damages hematopoietic stem cells (HSCs) by disrupting quiescence and promoting excessive terminal differentiation. However, the mechanism by which IFNγ hinders HSC quiescence remains undefined. Using intravital 3-dimensional microscopy, we find that IFNγ disrupts the normally close interaction between HSCs and CXCL12-abundant reticular (CAR) cells in the HSC niche. IFNγ stimulation increases expression of the cell surface protein BST2, which we find is required for IFNγ-dependent HSC relocalization and activation. IFNγ stimulation of HSCs increases their E-selectin binding by BST2 and homing to the bone marrow, which depends on E-selectin binding. Upon chronic infection, HSCs from mice lacking BST2 are more quiescent and more resistant to depletion than HSCs from wild-type mice. Overall, this study defines a critical mechanism by which IFNγ promotes niche relocalization and activation in response to inflammatory stimulation and identifies BST2 as a key regulator of HSC quiescence. VIDEO ABSTRACT.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D054377 Chemokine CXCL12 A CXC chemokine that is chemotactic for T-LYMPHOCYTES and MONOCYTES. It has specificity for CXCR4 RECEPTORS. Two isoforms of CXCL12 are produced by alternative mRNA splicing. CXCL12 Chemokine,Stromal Cell-Derived Factor-1beta,Chemokine (C-X-C Motif) Ligand 12,Pre-B-Cell Growth-Stimulating Factor,SDF-1alpha,SDF-1beta,SDF1-3'A,Stromal Cell-Derived Factor 1,Stromal Cell-Derived Factor-1alpha,CXCL12, Chemokine,Cell-Derived Factor-1beta, Stromal,Chemokine, CXCL12,Growth-Stimulating Factor, Pre-B-Cell,Pre B Cell Growth Stimulating Factor,SDF 1alpha,SDF 1beta,SDF1 3'A,Stromal Cell Derived Factor 1,Stromal Cell Derived Factor 1alpha,Stromal Cell Derived Factor 1beta

Related Publications

Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
April 2006, Annals of the New York Academy of Sciences,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
October 2012, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
December 2014, Developmental cell,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
January 2012, Frontiers in bioscience (Landmark edition),
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
October 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
July 1994, Leukemia & lymphoma,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
July 2014, Cell,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
April 2004, Discovery medicine,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
January 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Marcus A Florez, and Katie A Matatall, and Youngjae Jeong, and Laura Ortinau, and Paul W Shafer, and Anne M Lynch, and Roman Jaksik, and Marek Kimmel, and Dongsu Park, and Katherine Y King
October 2005, Cell cycle (Georgetown, Tex.),
Copied contents to your clipboard!